Biognosys attended the Discovering Precision Medicines meeting in Belfast at ELRIG.
Published
Signal category
Presence & Recognition
Quote
“Having a great time at ELRIG’s Discovering Precision Medicines meeting in Belfast”
— Kirsty Holden PhD|Biognosys team
Company
Biognosys
Omics made accessible
- Industry
- Biotechnology Research
- Location
- Schlieren, CH
- Company size
- 87 employees
The Biognosys Group brings together the Bruker Corporation affiliates Biognosys, biocrates, and PreOmics to deliver integrated solutions across proteomics, metabolomics, and lipidomics. The Group enables seamlessly connected mass spectrometry workflows, making advanced multiomics technologies accessible to laboratories worldwide. Its ecosystem spans high quality consumables, kits, software, and contract research services. Committed to a vendor-agnostic approach, the Biognosys Group supports open collaboration and broad compatibility across leading mass spectrometry platforms. All solutions are modular by design, allowing customers to choose the level of support that best fits their needs, from ready to use kits and software to guided implementation, or fully integrated end to end CRO services.
Founded 2008